[ Fri, Mar 05th 2021 ]: WOPRAI
[ Fri, Mar 05th 2021 ]: WOPRAI
[ Fri, Mar 05th 2021 ]: WOPRAI
[ Fri, Mar 05th 2021 ]: WOPRAI
[ Fri, Mar 05th 2021 ]: WOPRAI
[ Fri, Mar 05th 2021 ]: WOPRAI
[ Fri, Mar 05th 2021 ]: WOPRAI
[ Fri, Mar 05th 2021 ]: WOPRAI
[ Fri, Mar 05th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Thu, Mar 04th 2021 ]: WOPRAI
[ Wed, Mar 03rd 2021 ]: WOPRAI
[ Wed, Mar 03rd 2021 ]: WOPRAI
[ Wed, Mar 03rd 2021 ]: WOPRAI
[ Wed, Mar 03rd 2021 ]: WOPRAI
[ Wed, Mar 03rd 2021 ]: WOPRAI
[ Wed, Mar 03rd 2021 ]: WOPRAI
[ Wed, Mar 03rd 2021 ]: WOPRAI
[ Wed, Mar 03rd 2021 ]: WOPRAI
[ Wed, Mar 03rd 2021 ]: WOPRAI
Thomas Smith Maintained (ACRS) at Buy with Increased Target to $26 on, Mar 4th, 2021
- 🞛 This publication is a summary or evaluation of another publication
Thomas Smith of SVB Leerink, Maintained "Aclaris Therapeutics, Inc." (ACRS) at Buy with Increased Target from $21 to $26 on, Mar 4th, 2021.
Thomas, nor any peers, have made any analyst calls on ACRS in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30